AMGN
Amgen Inc.
NASDAQ · USHealthcareDrug Manufacturers - General
$364.17-0.58%
Price as of Jul 20, 2026
AMGN profitability
Amgen Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 71.5%
- EBITDA margin
- 44.8%
- EBIT margin
- 31.6%
- Net margin
- 20.9%
- Free cash flow margin
- 23.1%
Returns
- Return on equity
- 84.9%
- Return on assets
- 8.4%
- Return on invested capital
- 17.7%
- Asset turnover
- 0.41x
Cash efficiency
- Cash from operations
- $10.8B
- Cash per share
- $22
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.